Schizophrenia - First Head-To-Head Trial Of Oral Zyprexa Vs. Risperdal Consta (Risperidone Long-Acting Injection)
Newly-published data in the latest edition of the British Journal of Psychiatry (August 2007) show that patients receiving risperidone long-acting injection (Risperdal® ConstaTM) experienced a higher incidence of significant clinical improvements, as well as greater improvements in measures of disorganised thinking at 12 months than patients taking oral olanzapine (Zyprexa)1.
